Kitang, James .

HRN: 11-71-00  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/02/2024
07/09/2024
IV
600mg
Every 6 Hours
DM Foot
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamBone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: